KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Receivables - Net (2018 - 2025)

Historic Receivables - Net for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $807.6 million.

  • BioNTech SE's Receivables - Net rose 61602.42% to $807.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $807.6 million, marking a year-over-year increase of 61602.42%. This contributed to the annual value of $1.6 billion for FY2024, which is 3255.52% down from last year.
  • As of Q3 2025, BioNTech SE's Receivables - Net stood at $807.6 million, which was up 61602.42% from $35.1 million recorded in Q2 2025.
  • BioNTech SE's 5-year Receivables - Net high stood at $14.2 billion for Q1 2022, and its period low was $10.0 million during Q1 2024.
  • Over the past 5 years, BioNTech SE's median Receivables - Net value was $2.9 billion (recorded in 2021), while the average stood at $5.0 billion.
  • Per our database at Business Quant, BioNTech SE's Receivables - Net surged by 707819.92% in 2021 and then tumbled by 9985.56% in 2024.
  • BioNTech SE's Receivables - Net (Quarter) stood at $14.2 billion in 2021, then crashed by 48.53% to $7.3 billion in 2022, then tumbled by 68.18% to $2.3 billion in 2023, then plummeted by 32.56% to $1.6 billion in 2024, then tumbled by 48.37% to $807.6 million in 2025.
  • Its Receivables - Net was $807.6 million in Q3 2025, compared to $35.1 million in Q2 2025 and $24.4 million in Q1 2025.